Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPanthera Res. Regulatory News (PAT)

Share Price Information for Panthera Res. (PAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.25 (3.57%)
Spread: 0.50 (7.143%)
Open: 7.00
High: 7.25
Low: 6.38
Prev. Close: 7.00
PAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Warrant Conversion Commitments and Shares Admitted

14 Dec 2020 12:54

RNS Number : 5835I
Panthera Resources PLC
14 December 2020
 

14 December 2020

 

Panthera Resources plc

(Panthera or the Company)

 

Warrant Conversions Commitments and Correction of Shares Admitted to AIM

 

Panthera Resources Plc (AIM: PAT), the diversified gold exploration and development company with assets in West Africa and India, is pleased to announce that it has secured commitments of a further £118,766 for the early exercise of unlisted warrants in exchange for ordinary shares in the capital of the Company.

 

Highlights

· An additional 1,777,935 warrants to be exercised early for proceeds of £118,766 at an exercise price of 6.68 pence per warrant on or before 15 January 2021

· 1,438,289 shares issued to date pursuant to warrant conversions, with a further 360,055 warrants to be exercised shortly

· Total early warrant conversion commitments now comprise 3,576,279 warrants for £238,895

· Proceeds will accelerate our planned work programmes in West Africa

 

The Company announced on 9 November 2020, that 1,798,344 warrants were to be exercised on or before 27 November 2020 and that 1,798,344 new Ordinary Shares were to be admitted to trading on the AIM Market of the London Stock Exchange (AIM) on or before 3 December 2020. Of these warrants 1,438,289 have been exercised to date and due to the delayed receipt of the proceeds, the Company did not complete an application for any of these shares to be admitted to trading on AIM or update the total voting rights announcement. The Company will now apply for these 1,438,289 new Ordinary Shares to be admitted to trading on AIM as detailed below. The Company anticipates receiving the proceeds for the conversion of the remaining 366,055 warrants shortly and will apply for their admission upon receipt of the applicable proceeds.

 

Summary of Warrant Conversion Commitments

 

Number

GBP

Warrant Conversion Commitments

- Previous (9 Nov 2020)

1,798,344

120,129

- Additional (Dec 2020)

1,777,935

118,766

3,576,279

238,895

Less Converted (Dec 2020)

(1,438,289)

(96,078)

Balance of Outstanding Commitments

2,137,990

142,818

 

Warrant Conversions

 

The Company originally issued 4,747,149 warrants exercisable at 6.68 pence each on or before 20 December 2021 as part of the equity capital raising as announced on 15 May 2020. Following the conversion of 1,438,289 warrants announced today, the Company has 3,308,860 warrants on issue.

 

The Company announces that it has issued 1,438,289 new Ordinary Shares upon the conversion 1,438,289 warrants at 6.68 pence each for gross proceeds of £96,078.

 

Application will be made to the London Stock Exchange for 1,438,289 new Ordinary Shares to be admitted to trading on the AIM market with admission expected to occur on or around 17 December 2020 ("Admission"). The issued new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares.

 

Following Admission of the new Ordinary Shares, the issued ordinary share capital of Panthera will consist of 86,422,699 Ordinary Shares which is a correction to the Company's total voting rights announcement which was made on 9 November 2020.

 

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued Ordinary Share capital of Panthera following this allotment consists of 86,422,699 Ordinary Shares with voting rights attached (one vote per share). There are no shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Panthera under the DTRs.

 

There are no transaction and advisory fees payable for the early conversion of the warrants.

 

Mark Bolton, Managing Director of Panthera, commented:

 

"The Company expresses its thanks our shareholders once again for their ongoing support. These warrant holders have, at the Company's invitation, undertaken to exercise their warrants early. The exercise proceeds will assist the Company to accelerate its work programmes in West Africa."

 

Contacts

 

Panthera Resources PLC

Mark Bolton (Managing Director)

 

+61 411 220 942

contact@pantheraresources.com

Financial Public Relations

Vigo Communications Ltd

Simon Woods

Chris McMahon

Patrick d'Ancona

 

+44 (0)20 7390 0230

Nominated Advisor and Broker

RFC Ambrian

Rob Adamson

Bhavesh Patel

Charlie Cryer

+44 (0) 20 3440 6800

 

Subscribe for Regular Updates

 

Following the Company's Twitter page at @PantheraPLC

 

For more information and to subscribe for regular updates visit: www.pantheraresources.com

 

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

Forward-looking Statements

This news release contains forward-looking statements that are based on the Company's current expectations and estimates. Forward-looking statements are frequently characterised by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "suggest", "indicate" and other similar words or statements that certain events or conditions "may" or "will" occur. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such factors include, among others: the actual results of current exploration activities; conclusions of economic evaluations; changes in project parameters as plans continue to be refined; possible variations in ore grade or recovery rates; accidents, labour disputes, and other risks of the mining industry; delays in obtaining governmental approvals or financing; and fluctuations in metal prices. There may be other factors that cause actions, events, or results not to be as anticipated, estimated, or intended. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events, or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly, undue reliance should not be put on such statements due to the inherent uncertainty therein.

 

**ENDS**

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGPGGAPUPUGPC
Date   Source Headline
2nd Apr 20247:09 amRNSTotal Voting Rights
2nd Apr 20247:09 amRNSUpdate On Dispute With India
4th Mar 20247:00 amRNSShares in Lieu
9th Feb 20247:01 amRNSExercise of Wuo Land 2 Option
6th Feb 20249:22 amRNSKalaka and Bido Project Update
2nd Jan 20247:00 amRNSIssue of Notice of Dispute with India
29th Dec 20231:00 pmRNSTotal Voting Rights
29th Dec 20237:00 amRNSHalf-year Report
18th Dec 20237:38 amRNSEquity Financing Update
6th Dec 202310:22 amRNSEquity Financing
29th Nov 202310:30 amRNSResult of Meeting
9th Nov 20237:00 amRNSBhukia Update
31st Oct 20237:00 amRNSNotice of AGM
9th Oct 20237:00 amRNSKalaka Project Drilling Assay Results
27th Sep 20238:34 amRNSRajasthan High Court Decision
25th Aug 20237:00 amRNSFunding Confirmation Notice: US$13.6 million
22nd Aug 20237:13 amRNSArbitration Financing Update
21st Aug 202310:46 amRNSCompletion of Drilling at Kalaka
14th Aug 20237:00 amRNSArbitration Financing Update
31st Jul 20235:00 pmRNSTotal Voting Rights
31st Jul 20238:43 amRNSArbitration Financing Update
17th Jul 20238:07 amRNSArbitration Financing Update
11th Jul 20238:00 amRNSExecutive Service Agreement Variation
10th Jul 20237:00 amRNSKalaka Drilling Programme
4th Jul 20237:00 amRNSEquity Financing Update
3rd Jul 20237:00 amRNSArbitration Financing Update
28th Jun 202311:30 amRNSResult of Meeting
12th Jun 20237:00 amRNSNotice of GM
5th Jun 202312:28 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSArbitration Financing Update
25th May 20237:32 amRNSCascades Drilling Results
2nd May 20237:10 amRNSEquity Financing Update
2nd May 20237:00 amRNSOperations Update
19th Apr 20231:32 pmRNSEquity Issue Update
12th Apr 202310:13 amRNSDirector/PDMR Shareholding
29th Mar 20237:30 amRNSIssue of Equity
8th Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20232:05 pmRNSSecond Price Monitoring Extn
8th Mar 20232:00 pmRNSPrice Monitoring Extension
3rd Mar 20234:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSArbitration Funding for up to US$10.5 million
13th Feb 20237:00 amRNS10000m Drilling Programme Commenced at Cascades
23rd Dec 20229:14 amRNSHalf Year Report 30 September 2022
23rd Nov 202211:36 amRNSResult of AGM
12th Oct 20227:00 amRNSBido Exploration Update
10th Oct 20221:32 pmRNSEquity Financing Update
5th Oct 202212:17 pmRNSTotal Voting Rights
3rd Oct 20221:27 pmRNSEquity Financing
30th Sep 20222:08 pmRNSAnnual Financial Report 31 March 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.